Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Can ÖzütemizLuke A KrystosekAn Ly ChurchAnil ChauhanJutta M EllermannEvidio Domingo-MusibayDaniel SteinbergerPublished in: Radiology (2021)
Five cases of axillary lymphadenopathy are presented, which occurred after COVID-19 vaccination and mimicked metastasis in a vulnerable oncologic patient group. Initial radiologic diagnosis raised concerns for metastasis. However, further investigation revealed that patients received COVID-19 vaccinations in the ipsilateral arm prior to imaging. In two cases, lymph node biopsy results confirmed vaccination-related reactive lymphadenopathy. Ipsilateral axillary swelling or lymphadenopathy was reported based on symptoms and physical examination in COVID-19 vaccine trials. Knowledge of the potential for COVID-19 vaccine-related ipsilateral adenopathy is necessary to avoid unnecessary biopsy and change in therapy. © RSNA, 2021.
Keyphrases
- coronavirus disease
- sars cov
- lymph node
- end stage renal disease
- fine needle aspiration
- ejection fraction
- ultrasound guided
- chronic kidney disease
- newly diagnosed
- healthcare
- peritoneal dialysis
- prognostic factors
- prostate cancer
- high resolution
- sentinel lymph node
- physical activity
- stem cells
- squamous cell carcinoma
- mental health
- robot assisted
- radical prostatectomy
- radiation therapy
- bone marrow
- single cell
- minimally invasive
- climate change
- smoking cessation
- locally advanced